Literature DB >> 17525742

IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response.

M Andrianifahanana1, A P Singh, C Nemos, M P Ponnusamy, N Moniaux, P P Mehta, G C Varshney, S K Batra.   

Abstract

MUC4 is a transmembrane mucin, which is aberrantly expressed in pancreatic adenocarcinoma with no detectable expression in the normal pancreas. Here, we present a novel mechanism of IFN-gamma-induced expression of MUC4 in pancreatic cancer cells. Our studies highlight the upregulation of STAT-1 as a basis for MUC4 induction and demonstrate that its activation and upregulation by IFN-gamma are two distinct, albeit temporally integrated, signalling events that drive the selective induction of IRF-1 and MUC4, respectively, within a single cell system. The profile of interferon regulatory factor (IRF)-1 gene induction by IFN-gamma is consistent with its rapid transactivation by phospho-Y701-STAT-1. In contrast, the induction of the MUC4 mucin gene expression is relatively delayed, and occurs only in response to an increase in STAT-1 expression. A progressive binding of STAT-1 to various gamma-interferon-activated sequences (GAS) in the MUC4 promoter is observed in chromatin immunoprecipitation assay, indicating its direct association. Stimulation of STAT-1 expression by double-stranded polynucleotides or ectopic expression is shown to induce MUC4 expression, without Y701 phosphorylation of STAT-1. This effect is abrogated by short interfering RNA (siRNA)-mediated inhibition of STAT-1 expression, supporting further the relevance of STAT-1 in MUC4 regulation. In conclusion, our findings identify a novel mechanism for MUC4 regulation in pancreatic cancer cells and unfold new perspectives on the foundation of IFN-gamma-dependent gene regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525742     DOI: 10.1038/sj.onc.1210532

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.

Authors:  Maria P Torres; Moorthy P Ponnusamy; Subhankar Chakraborty; Lynette M Smith; Srustidhar Das; Hwyda A Arafat; Surinder K Batra
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

2.  Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.

Authors:  Albert C Chen; Ilenia Migliaccio; Mothaffar Rimawi; Sara Lopez-Tarruella; Chad J Creighton; Suleiman Massarweh; Catherine Huang; Yen-Chao Wang; Surinder K Batra; M Carolina Gutierrez; C Kent Osborne; Rachel Schiff
Journal:  Breast Cancer Res Treat       Date:  2012-05-29       Impact factor: 4.872

3.  Transcriptional regulation of human mucin gene MUC4 in pancreatic cancer cells.

Authors:  Jingjing Zhang; Xiongfei Zhang; Yi Zhu; Zheng Chen; Zekuan Xu; Yi Miao
Journal:  Mol Biol Rep       Date:  2009-09-16       Impact factor: 2.316

Review 4.  Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.

Authors:  Muzafar A Macha; Shiv Ram Krishn; Rahat Jahan; Kasturi Banerjee; Surinder K Batra; Maneesh Jain
Journal:  Cancer Treat Rev       Date:  2015-01-14       Impact factor: 12.111

5.  Transmembrane mucins as novel therapeutic targets.

Authors:  Pamela E Constantinou; Brian P Danysh; Neeraja Dharmaraj; Daniel D Carson
Journal:  Expert Rev Endocrinol Metab       Date:  2011-11

Review 6.  Mucin dynamics and enteric pathogens.

Authors:  Michael A McGuckin; Sara K Lindén; Philip Sutton; Timothy H Florin
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

7.  Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.

Authors:  Yi-Mi Wu; D David Nowack; Gilbert S Omenn; Brian B Haab
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

8.  Transcriptional regulation of human MUC4 gene: identification of a novel inhibitory element and its nuclear binding protein.

Authors:  Jing-Jing Zhang; Yi Zhu; Xiong-Fei Zhang; Wen-Biao Liang; Kun-Ling Xie; Jin-Qiu Tao; Yun-Peng Peng; Ze-Kuan Xu; Yi Miao
Journal:  Mol Biol Rep       Date:  2013-06-30       Impact factor: 2.316

9.  Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.

Authors:  Muzafar A Macha; Satyanarayana Rachagani; Suprit Gupta; Priya Pai; Moorthy P Ponnusamy; Surinder K Batra; Maneesh Jain
Journal:  Cancer Lett       Date:  2013-08-03       Impact factor: 8.679

10.  The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.

Authors:  Priya Pai; Satyanarayana Rachagani; Imayavaramban Lakshmanan; Muzafar A Macha; Yuri Sheinin; Lynette M Smith; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Mol Oncol       Date:  2015-10-19       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.